Drug Shortage Report for MINT-PIOGLITAZONE
Report ID | 88502 |
Drug Identification Number | 02326477 |
Brand name | MINT-PIOGLITAZONE |
Common or Proper name | Pioglitazone |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | PIOGLITAZONE |
Strength(s) | 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | A10BG |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-07-04 |
Estimated end date | 2021-12-31 |
Actual end date | 2022-03-03 |
Shortage status | Resolved |
Updated date | 2023-01-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-04 | English | Compare |
v2 | 2019-07-04 | French | Compare |
v3 | 2019-07-05 | English | Compare |
v4 | 2020-01-27 | English | Compare |
v5 | 2020-01-27 | French | Compare |
v6 | 2020-04-09 | English | Compare |
v7 | 2020-04-09 | French | Compare |
v8 | 2020-04-25 | English | Compare |
v9 | 2020-04-25 | French | Compare |
v10 | 2021-08-13 | English | Compare |
v11 | 2021-08-13 | French | Compare |
v12 | 2023-01-03 | English | Compare |
v13 | 2023-01-03 | French | Compare |
Showing 1 to 13 of 13